San Diego, CA, United States of America

Pablo Garcia-Reynaga

USPTO Granted Patents = 9 

 

Average Co-Inventor Count = 4.4

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2022-2024

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Pablo Garcia-Reynaga

Introduction

Pablo Garcia-Reynaga is a prominent inventor based in San Diego, California. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target various medical conditions. With a total of nine patents to his name, Garcia-Reynaga's work has the potential to impact numerous therapeutic areas.

Latest Patents

Among his latest patents are "Substituted cyclohexyl compounds as NOP inhibitors" and "Aminocyclobutanes as monoacylglycerol lipase modulators." The first patent focuses on cyclohexyl chemical entities that serve as inhibitors, while the second patent details aminocyclobutane compounds and their pharmaceutical applications. These inventions include methods for treating a range of disorders, including pain, psychiatric conditions, and various cancers.

Career Highlights

Garcia-Reynaga has worked with notable companies in the pharmaceutical industry, including Janssen Pharmaceutica and Dart Neuroscience, LLC. His experience in these organizations has allowed him to develop innovative solutions that address complex medical challenges.

Collaborations

Throughout his career, Garcia-Reynaga has collaborated with esteemed colleagues such as Michael K. Ameriks and Cynthia B. Berry. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

Pablo Garcia-Reynaga's contributions to the field of pharmaceuticals through his innovative patents demonstrate his commitment to improving healthcare. His work continues to pave the way for new treatments and therapies that can benefit patients worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…